PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL DOSAGE FORM COMPRISING (E)-4-(2-(AMINOMETHYL)-3-FLUOROALLYLOXY)-N-TERT-BUTYLBENZAMIDE, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
The present invention relates to pharmaceutical compositions comprising (E)-4-(2- (aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide having chemical structure (I) or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment.